ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Another firm shuts down in Pakistan due to import ban

KSB Pumps company announced that it will shut down its Hasanabdal production plant in Pakistan.

ANI Jan 03, 2023 07:41 IST googleads

Representative Image

Islamabad [Pakistan], January 3 (ANI): After Pak Suzuki Motor Company Limited, engineering services company KSB Pumps Company Limited also announced that the production plant would shut down due to an import ban, ARY News reported.
KSB Pumps company announced that it will shut down its Hasanabdal production plant in Pakistan.
The Frankenthal-based multinational engineering services company, KSBP, is a subsidiary of KSB SE and Co. KGaA is a manufacturer of industrial pumps, valves, castings and related parts and after-market services, according to ARY News.
The company, in the statement, said that this will be a temporary suspension till further notice, due to import restrictions. The company will resume operations as soon as the market situation improves and staff may be readily recalled on short notice, it read.
Earlier, an automobile company, Pak Suzuki Motor Company Limited, announced to shut down its production plant from January 2 to 6.
Pakistan Suzuki Motors wrote a letter to the Pakistan Stock Exchange (PSX) that the production process of cars and motorcycles will be completely shut down from January 2 to 6, according to ARY News.
According to the automobile company, the management decided the shut down due to conditional permission for the imports of the auto parts and completely knocked down (CKD) kits. The firm stated that its supply chain is affected due to the State Bank of Pakistan (SBP) restriction.
The company further added that the restrictions are affecting the export consignments
In December, another automobile firm, Indus Motor Company (IMC), announced to shut down its manufacturing plant for 10 days due to the ban on imports of completely knocked down (CKD) kits by the central bank.
The Indus Motor Company, the maker of Toyota vehicles, has announced the ban on their manufacturing plant from December 20 to 30. It stated that the decision was taken after a ban on the imports of completely knocked down (CKD) kits by the State Bank of Pakistan (SBP), ARY News reported. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Europe

Indian Rights Activist raises cadaver organ donation issue at UN

Indian Rights Activist raises cadaver organ donation issue at UN

Gobind Gurbani, speaking through video conference, drew attention to the growing gap between the number of patients requiring organ transplants and the limited availability of donated organs.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.